Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Phase III Study of ASP1941 –A Phase III, Randomized, Double-Blind, Placebo-controlled, Monotherapy Study to Assess the Efficacy, Safety, and Tolerability of ASP1941 in Japanese Patients with Type 2 Diabetes Mellitus–
ipragliflozin
1941-CL-0105
NCT01057628
Diabetes Mellitus, Type 2
Phase 3
 
Formats available for datasets without specifications
January 2017

Powered by ideaPoint, Inc.